NO20013636D0 - Fremgangsmåter for å danne fosforylerings-stedsspesifikke immunologiske reagenser - Google Patents

Fremgangsmåter for å danne fosforylerings-stedsspesifikke immunologiske reagenser

Info

Publication number
NO20013636D0
NO20013636D0 NO20013636A NO20013636A NO20013636D0 NO 20013636 D0 NO20013636 D0 NO 20013636D0 NO 20013636 A NO20013636 A NO 20013636A NO 20013636 A NO20013636 A NO 20013636A NO 20013636 D0 NO20013636 D0 NO 20013636D0
Authority
NO
Norway
Prior art keywords
mimetic
linkage
polypeptide
produce
methods
Prior art date
Application number
NO20013636A
Other languages
English (en)
Other versions
NO20013636L (no
Inventor
Carl W Anderson
Ettore Appella
Kazuyasu Sakaguchi
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of NO20013636D0 publication Critical patent/NO20013636D0/no
Publication of NO20013636L publication Critical patent/NO20013636L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20013636A 1999-01-25 2001-07-24 Fremgangsmåter for å danne fosforylerings-stedsspesifikke immunologiske reagenser NO20013636L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/236,415 US6309863B1 (en) 1999-01-25 1999-01-25 Methods for generating phosphorylation site-specific immunological reagents
PCT/US2000/001796 WO2000043422A1 (en) 1999-01-25 2000-01-25 Methods for generating phosphorylation site-specific immunological reagents

Publications (2)

Publication Number Publication Date
NO20013636D0 true NO20013636D0 (no) 2001-07-24
NO20013636L NO20013636L (no) 2001-09-19

Family

ID=22889404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013636A NO20013636L (no) 1999-01-25 2001-07-24 Fremgangsmåter for å danne fosforylerings-stedsspesifikke immunologiske reagenser

Country Status (16)

Country Link
US (1) US6309863B1 (no)
EP (1) EP1147137B9 (no)
JP (1) JP3891542B2 (no)
AT (1) ATE324382T1 (no)
AU (1) AU767969B2 (no)
BR (1) BR0008977A (no)
CA (1) CA2360511C (no)
DE (1) DE60027542T2 (no)
HU (1) HUP0105309A3 (no)
IL (2) IL144471A0 (no)
MX (1) MXPA01007323A (no)
NO (1) NO20013636L (no)
NZ (1) NZ512868A (no)
UA (1) UA73109C2 (no)
WO (1) WO2000043422A1 (no)
ZA (1) ZA200105520B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030162230A1 (en) * 2000-09-27 2003-08-28 Reagan Kevin J. Method for quantifying phosphokinase activity on proteins
WO2003057238A1 (en) * 2001-12-28 2003-07-17 Oregon Health & Science University Agents that recognize src when phosphorylated at serine 17
US7452676B2 (en) * 2003-01-16 2008-11-18 Uti Limited Partnership Monoclonal antibodies to RNA binding protein GW182
US20090081659A1 (en) * 2007-03-07 2009-03-26 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
US20090304714A1 (en) * 2008-03-25 2009-12-10 The Regents Of The University Of Michigan IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
US8445706B2 (en) * 2008-09-05 2013-05-21 Board Of Trustees Of Northern Illinois University Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
EP2576614A4 (en) * 2010-05-24 2013-11-13 Phosimmune Inc MHC CLASS I PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
EP2675275B1 (en) 2011-02-14 2017-12-20 The Regents Of The University Of Michigan Compositions and methods for the treatment of obesity and related disorders
EP2854842A4 (en) 2012-05-25 2016-11-02 Agenus Inc IDENTIFICATION OF BREAST CANCER CLASS I MHC PHOSPHOPEPTIDE ANTIGENS USING SHLA TECHNOLOGY AND COMPLEMENTARY ENRICHMENT STRATEGIES
CA2883569A1 (en) 2012-08-31 2014-03-06 University Of Virginia Patent Foundation Target peptides for immunotherapy and diagnostics
WO2014039675A2 (en) 2012-09-05 2014-03-13 University Of Virginia Patent Foundation Target peptides for colorectal cancer therapy and diagnostics
WO2014179734A1 (en) 2013-05-02 2014-11-06 The Regents Of The University Of Michigan Deuterated amlexanox
AU2015247727A1 (en) 2014-04-15 2016-11-03 University Of Virginia Patent Foundation Isolated T cell receptors and methods of use therefor
WO2017132538A1 (en) 2016-01-29 2017-08-03 The Regents Of The University Of Michigan Amlexanox analogs
CN106046047B (zh) * 2016-05-26 2018-10-02 清华大学 制备磷酸化丝氨酸膦酸模拟物的方法
IL311633A (en) * 2021-09-27 2024-05-01 Abbratech Inc Compounds and methods for preparing site-specific conformational and linear antibodies and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543439A (en) * 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
DE4009848A1 (de) * 1990-03-27 1991-10-02 Boehringer Mannheim Gmbh Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
CA2117913C (en) * 1992-04-10 2006-05-09 Richard J. Epstein Activation-state-specific phosphoprotein immunodetection
EP0682704A1 (en) * 1993-02-12 1995-11-22 The Salk Institute For Biological Studies Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide
US6495356B1 (en) * 1999-11-30 2002-12-17 The Regents Of The University Of California Beryllofluoride analogues of acyl phosphate polypeptides

Also Published As

Publication number Publication date
HUP0105309A2 (hu) 2002-04-29
NO20013636L (no) 2001-09-19
DE60027542D1 (de) 2006-06-01
EP1147137B9 (en) 2006-11-02
ATE324382T1 (de) 2006-05-15
EP1147137B1 (en) 2006-04-26
US6309863B1 (en) 2001-10-30
JP2003517451A (ja) 2003-05-27
EP1147137A4 (en) 2004-12-29
JP3891542B2 (ja) 2007-03-14
AU3582800A (en) 2000-08-07
CA2360511C (en) 2012-04-10
AU767969B2 (en) 2003-11-27
NZ512868A (en) 2003-11-28
UA73109C2 (en) 2005-06-15
EP1147137A1 (en) 2001-10-24
HUP0105309A3 (en) 2004-09-28
BR0008977A (pt) 2002-02-13
IL144471A0 (en) 2002-05-23
CA2360511A1 (en) 2000-07-27
WO2000043422A1 (en) 2000-07-27
DE60027542T2 (de) 2007-05-03
MXPA01007323A (es) 2002-06-04
ZA200105520B (en) 2002-01-17
IL144471A (en) 2006-06-11

Similar Documents

Publication Publication Date Title
NO20013636D0 (no) Fremgangsmåter for å danne fosforylerings-stedsspesifikke immunologiske reagenser
DE69503903T2 (de) Positive und positive/negative zellselektion vermittelt durch peptiofreisetzung
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
Schmiedeke et al. Glomerular immune deposits in murine lupus models may contain histones
US10954298B2 (en) Method of obtaining a binder to prepro-vasopressin or fragments thereof
JP2003517451A5 (no)
WO1999031279A1 (en) A serological assay for herpes
Weldon et al. Monoclonal antibodies as structural probes of surface residues in the regulatory subunit of cAMP-dependent protein kinase II from porcine heart.
EP2535715B1 (en) METHOD FOR MEASURING IMMUNITY OF COMPLEX OF Ku86 AND AUTOANTIBODY THEREOF, KIT USED THEREFOR, AND METHOD FOR DETERMINING CANCER USING SAME
GB2171999A (en) Antibodies
Munns et al. Antibody-nucleic acid complexes. Antigenic domains within nucleosides as defined by solid-phase immunoassay
WO1991017177A1 (en) High affinity antibodies to small peptides
Bassett et al. STUDIES ON HUMAN ANTIBODIES: III. Amino Acid Composition of Four Antibodies from One Individual
Fischer et al. Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody
JP2001183375A (ja) 酵素標識抗体
Mangler et al. New monoclonal antibodies to triazine herbicides
KR950026888A (ko) 사카로마이세스-특이적 항원 및 항체, 이의 제조방법 및 용도
Xu The interaction of phosphorylase kinase with glycogen phosphorylase.
Kaihara et al. Monoclonal anti-human aldolase C antibodies that react to the isozyme group-specific sequences and generally conserved sequences of human aldolase C
ATE334192T1 (de) Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide
EW et al. STUDIES ON HUMAN ANTIBODIES. 3. AMINO ACID COMPOSITION OF FOUR ANTIBODIES FROM ONE INDIVIDUAL.
GB9725105D0 (en) Diagnosis of autoimmune adrenal disease
EP1734054A3 (en) Anti-human thymidylate synthase monoclonal antibody and hybridoma capable of producing the same
UA39209C2 (uk) Моноклональне антитіло, що інгібує хомінг кровотворних стовбурових клітин і розпізнає поверхневий антіген стромальної клітини селезінки, гібридома, яка його продукує
NZ335545A (en) Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application